Wells Fargo raised the firm’s price target on Universal Health (UHS) to $249 from $210 and keeps an Overweight rating on the shares. The firm is updating estimates and price targets in the space ahead of Q3 2025 results. Notability, Wells now assumes extension of enhanced subsidies is likely.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Universal Health Faces $500 Million Verdict in Nevada
- Universal Health price target lowered to $250 from $259 at Barclays
- Ex-Dividend Date Nearing for These 10 Stocks – Week of September 1, 2025
- Universal Health price target raised to $206 from $201 at RBC Capital
- Universal Health price target lowered to $203 from $243 at Baird